G. Seerp Baarsma

Bevacizumab in age‐related macular degeneration: a randomized controlled trial on the effect of injections every 4 weeks, 6 weeks and 8 weeks

Sankha Amarakoon, T. Missotten, L. I. van den Born, 2013, Acta ophthalmologica.